Bloomberg Stock Movers
2026-06-09 · Hosted by — · Bloomberg / iHeartMedia
Executive Summary
This Bloomberg Stock Movers report led with Nuvalent surging ~39% pre-market on news that GSK agreed to buy the Cambridge biotech for $124 a share to rebuild its cancer pipeline. Apple slipped ~0.3% as investors stayed unconvinced by the WWDC “Siri AI” reveal, drawing sharply mixed analyst reviews. Neocloud operator Applied Digital jumped nearly 11% on a 15-year, $5.2 billion hyperscaler lease, and Vail Resorts fell ~4% after cutting full-year guidance on poor snowfall.
Key Stories & Changes
1. Nuvalent / GSK Merger
Nuvalent (NUVL) up ~39% pre-market; GSK agreed to acquire it for $124/share
GSK is rebuilding its cancer pipeline after slow growth since returning to oncology in 2019
Nuvalent has two medicines in late-stage trials; FDA decisions on both due this year, and GSK says they could be blockbusters if approved
2. Apple WWDC Skepticism
Apple (AAPL) down ~0.3% pre-market; investors “still not convinced” after the WWDC keynote
New overhauled assistant branded Siri AI is the centerpiece of new operating systems
Mixed analyst reviews: Wedbush bullish (“unveiled an AI strategy that will unleash the true monetization opportunity”); Vital Knowledge called the keynote “a disappointment”
Key issue is timelines — a long-term strategy Wall Street is still trying to price
3. Applied Digital Hyperscaler Deal
Applied Digital (APLD) up nearly 11% pre-market; neocloud (specialized AI infrastructure) operator
Signed a 15-year lease with a US-based hyperscaler for 210 megawatts at its Delta 4.2 campus
$5.2 billion in base-term revenue, up to nearly $13 billion over a 30-year term
Notable: Delta 4.2 isn’t expected to open until ~2028, signaling strong forward demand
Dragged peers higher: CoreWeave +3%, Nebius +4% pre-market
4. Vail Resorts Earnings
Vail Resorts (MTN) down ~4% pre-market after cutting full-year net income guidance
Sees 2026 EBITDA down 14% from its original September forecast on “historically challenging weather”
Rocky Mountain resorts saw a 24% drop in visits
Pre-Market Movers Summary
NUVL: Nuvalent — +~39% — GSK to acquire at $124/share to rebuild cancer pipeline
APLD: Applied Digital — +~11% — 15-yr, $5.2B hyperscaler lease at Delta 4.2
AAPL: Apple — -~0.3% — Investors unconvinced by Siri AI; mixed reviews
MTN: Vail Resorts — -~4% — Guidance cut on poor snowfall, visits down 24%
CRWV: CoreWeave — +3% — Lifted in sympathy with Applied Digital deal
NBIS: Nebius — +4% — Lifted in sympathy with Applied Digital deal
Trends Identified
1. Pharma M&A to Rebuild Pipelines
GSK’s $124/share bid for Nuvalent shows large pharma using acquisitions to re-enter and expand in oncology, paying a steep premium for late-stage assets with potential blockbuster approvals due this year.
2. Forward-Booked AI Infrastructure Demand
Applied Digital’s 15-year lease for a campus that won’t open until 2028 — and the sympathetic moves in CoreWeave and Nebius — underscores how hyperscalers are locking up specialized AI compute years in advance, a durable demand signal for neocloud operators.
3. Apple’s AI Reveal Splits Wall Street
The polarized Wedbush-vs-Vital-Knowledge reaction captures genuine uncertainty over Apple’s Siri AI strategy, with the debate centered on execution timelines rather than the vision itself. —-
Sentiment Analysis
Overall Market Sentiment: Mixed
A merger-driven biotech pop and a strong AI-infrastructure deal lifted spirits, offset by lingering Apple skepticism and a weather-hit Vail.
Risk Factors Highlighted
FDA approval risk: Nuvalent’s blockbuster case depends on two pending FDA decisions this year.
Apple timeline uncertainty: Siri AI is a long-term strategy whose payoff timing is unclear to Wall Street.
Forward-demand execution: Applied Digital’s revenue hinges on a Delta 4.2 campus not opening until ~2028.
Weather/operational risk: Vail’s 24% visit drop shows how poor snowfall can force guidance cuts.
Analyst dispersion: Sharply divided Apple reviews signal elevated uncertainty around the AI thesis.
This episode was covered in today’s The Market Signal — 2026-06-09, a cross-source synthesis of multiple podcast reports.